Clinical Trial Update: Pharmacokinetic And Pharmacodynamic Study Of A Single-Dose Of PF-04950615 (RN316) In Combination With Atorvastatin [Phase 1]

View source ↗

Summary

A Phase 1 pharmacokinetic and pharmacodynamic study evaluated a single dose of PF-04950615 (RN316) in combination with atorvastatin in individuals with hypercho…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia
• Hypercholesterolemia

Drugs mentioned

• PF-04950615 (RN316) (PF-04950615)
• atorvastatin (atorvastatin)

Snippet

Sponsor: Pfizer | Conditions: Hypercholesterolemia, Dyslipidemia | Phase 1 | Status: COMPLETED | Results posted: 2015-05-07